Anton W. Fetting

Array ( [id] => 3729619 [patent_doc_number] => 05693530 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Marek\'s disease virus nucleotide sequence and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/480910 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 11518 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693530.pdf [firstpage_image] =>[orig_patent_app_number] => 480910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3699253 [patent_doc_number] => 05645999 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Assays for compounds that modulate or alter cyclin E activity' [patent_app_type] => 1 [patent_app_number] => 8/485859 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 43 [patent_no_of_words] => 30678 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/645/05645999.pdf [firstpage_image] =>[orig_patent_app_number] => 485859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3931418 [patent_doc_number] => 05928891 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'DNA fragment encoding insecticidal crystal proteins from Bacillus thuringiensis' [patent_app_type] => 1 [patent_app_number] => 8/487644 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4013 [patent_no_of_claims] => 123 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/928/05928891.pdf [firstpage_image] =>[orig_patent_app_number] => 487644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3759332 [patent_doc_number] => 05851832 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'In vitro growth and proliferation of multipotent neural stem cells and their progeny' [patent_app_type] => 1 [patent_app_number] => 8/486648 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 36227 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/851/05851832.pdf [firstpage_image] =>[orig_patent_app_number] => 486648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3989073 [patent_doc_number] => 05919458 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Non-infectious HIV particles and uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/477081 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 10765 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 420 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919458.pdf [firstpage_image] =>[orig_patent_app_number] => 477081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3870128 [patent_doc_number] => 05747028 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Immunizing compositions comprising Vibrio cholerae expressing heterologous antigens' [patent_app_type] => 1 [patent_app_number] => 8/480510 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 6791 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747028.pdf [firstpage_image] =>[orig_patent_app_number] => 480510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3804062 [patent_doc_number] => 05811075 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Method and agents for removing advanced glycosylation endproducts' [patent_app_type] => 1 [patent_app_number] => 8/487398 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11111 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811075.pdf [firstpage_image] =>[orig_patent_app_number] => 487398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3893686 [patent_doc_number] => 05750376 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny' [patent_app_type] => 1 [patent_app_number] => 8/483122 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 36200 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750376.pdf [firstpage_image] =>[orig_patent_app_number] => 483122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3836081 [patent_doc_number] => 05846827 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of CTL' [patent_app_type] => 1 [patent_app_number] => 8/468454 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 11998 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846827.pdf [firstpage_image] =>[orig_patent_app_number] => 468454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4011343 [patent_doc_number] => 05889174 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Nucleotide sequences encoding pesticidal proteins' [patent_app_type] => 1 [patent_app_number] => 8/470567 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28078 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/889/05889174.pdf [firstpage_image] =>[orig_patent_app_number] => 470567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3866354 [patent_doc_number] => 05837510 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders' [patent_app_type] => 1 [patent_app_number] => 8/472056 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11961 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837510.pdf [firstpage_image] =>[orig_patent_app_number] => 472056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729689 [patent_doc_number] => 05635399 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Retroviral vectors expressing cytokines' [patent_app_type] => 1 [patent_app_number] => 8/467553 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6806 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635399.pdf [firstpage_image] =>[orig_patent_app_number] => 467553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105564 [patent_doc_number] => 06022712 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene' [patent_app_type] => 1 [patent_app_number] => 8/466548 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 7 [patent_no_of_words] => 11502 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022712.pdf [firstpage_image] =>[orig_patent_app_number] => 466548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3805394 [patent_doc_number] => 05830849 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Vampire bat salivary plasminogen activators' [patent_app_type] => 1 [patent_app_number] => 8/467966 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10541 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830849.pdf [firstpage_image] =>[orig_patent_app_number] => 467966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3785212 [patent_doc_number] => 05736391 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'HIV gp41 mutants' [patent_app_type] => 1 [patent_app_number] => 8/467933 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 19 [patent_no_of_words] => 8075 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736391.pdf [firstpage_image] =>[orig_patent_app_number] => 467933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3799934 [patent_doc_number] => 05830475 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Recombinant mycobacterial vaccines' [patent_app_type] => 1 [patent_app_number] => 8/460981 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 10862 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830475.pdf [firstpage_image] =>[orig_patent_app_number] => 460981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686725 [patent_doc_number] => 05691177 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => 'Recombinant retroviruses expressing a protein that converts a pro-drug into a cytotoxic agent' [patent_app_type] => 1 [patent_app_number] => 8/460996 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 31 [patent_no_of_words] => 23781 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/691/05691177.pdf [firstpage_image] =>[orig_patent_app_number] => 460996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4061308 [patent_doc_number] => 05866361 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Nucleotide sequence encoding the enzyme I-SceI and the uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/465273 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 65 [patent_no_of_words] => 24291 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866361.pdf [firstpage_image] =>[orig_patent_app_number] => 465273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3879150 [patent_doc_number] => 05776465 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Recombinant mycobacterial vaccines' [patent_app_type] => 1 [patent_app_number] => 8/461725 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 10861 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/776/05776465.pdf [firstpage_image] =>[orig_patent_app_number] => 461725 [rel_patent_id] =>[rel_patent_doc_number] =>)